Stock Analysis on Net
Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

この会社は アーカイブに移動しました! 財務データは2024年5月6日以降更新されていません。

デュポンの分析: ROE、ROA、純利益率の内訳 
四半期データ

Microsoft Excel

ROE分解では、純利益を株主資本で割ったものを構成比率の積として表します。

ROEを2つのコンポーネントに分解

Shockwave Medical Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = ROA × 財務レバレッジ比率
2024/03/31 21.75% = 9.95% × 2.19
2023/12/31 22.03% = 9.40% × 2.34
2023/09/30 40.56% = 16.55% × 2.45
2023/06/30 39.54% = 31.01% × 1.28
2023/03/31 42.16% = 30.72% × 1.37
2022/12/31 42.24% = 33.43% × 1.26
2022/09/30 24.73% = 18.50% × 1.34
2022/06/30 18.02% = 13.18% × 1.37
2022/03/31 10.82% = 7.78% × 1.39
2021/12/31 -3.78% = -2.64% × 1.43
2021/09/30 -17.23% = -12.69% × 1.36
2021/06/30 -25.36% = -19.12% × 1.33
2021/03/31 -34.53% = -26.21% × 1.32
2020/12/31 -29.11% = -24.15% × 1.21
2020/09/30 -27.24% = -23.01% × 1.18
2020/06/30 -26.32% = -22.48% × 1.17
2020/03/31 -32.11% = -25.86% × 1.24
2019/12/31 -26.53% = -22.04% × 1.20
2019/09/30 — = — × 1.27
2019/06/30 — = — × 1.23
2019/03/31 — = — × 1.22

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期の株主資本利益率(ROE)が低下した主な理由は、財務レバレッジ比率の低下です。

ROEを3つの要素に分解

Shockwave Medical Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 純利益率 × 資産回転率 × 財務レバレッジ比率
2024/03/31 21.75% = 20.75% × 0.48 × 2.19
2023/12/31 22.03% = 20.17% × 0.47 × 2.34
2023/09/30 40.56% = 36.33% × 0.46 × 2.45
2023/06/30 39.54% = 39.56% × 0.78 × 1.28
2023/03/31 42.16% = 43.18% × 0.71 × 1.37
2022/12/31 42.24% = 44.10% × 0.76 × 1.26
2022/09/30 24.73% = 20.48% × 0.90 × 1.34
2022/06/30 18.02% = 15.11% × 0.87 × 1.37
2022/03/31 10.82% = 9.70% × 0.80 × 1.39
2021/12/31 -3.78% = -3.85% × 0.69 × 1.43
2021/09/30 -17.23% = -21.60% × 0.59 × 1.36
2021/06/30 -25.36% = -40.60% × 0.47 × 1.33
2021/03/31 -34.53% = -83.47% × 0.31 × 1.32
2020/12/31 -29.11% = -96.92% × 0.25 × 1.21
2020/09/30 -27.24% = -108.73% × 0.21 × 1.18
2020/06/30 -26.32% = -126.34% × 0.18 × 1.17
2020/03/31 -32.11% = -112.25% × 0.23 × 1.24
2019/12/31 -26.53% = -119.06% × 0.19 × 1.20
2019/09/30 — = — × — × 1.27
2019/06/30 — = — × — × 1.23
2019/03/31 — = — × — × 1.22

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期の株主資本利益率(ROE)が低下した主な理由は、財務レバレッジ比率の低下です。

ROEを5つの要素に分解

Shockwave Medical Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 税負担 × 利息負担 × EBITマージン × 資産回転率 × 財務レバレッジ比率
2024/03/31 21.75% = 0.89 × 0.95 × 24.46% × 0.48 × 2.19
2023/12/31 22.03% = 0.85 × 0.96 × 24.81% × 0.47 × 2.34
2023/09/30 40.56% = 1.49 × 0.97 × 25.09% × 0.46 × 2.45
2023/06/30 39.54% = 1.59 × 0.98 × 25.34% × 0.78 × 1.28
2023/03/31 42.16% = 1.64 × 0.99 × 26.76% × 0.71 × 1.37
2022/12/31 42.24% = 1.79 × 0.98 × 25.06% × 0.76 × 1.26
2022/09/30 24.73% = 0.99 × 0.99 × 21.04% × 0.90 × 1.34
2022/06/30 18.02% = 0.98 × 0.98 × 15.72% × 0.87 × 1.37
2022/03/31 10.82% = 0.98 × 0.96 × 10.21% × 0.80 × 1.39
2021/12/31 -3.78% = — × — × -3.26% × 0.69 × 1.43
2021/09/30 -17.23% = — × — × -20.86% × 0.59 × 1.36
2021/06/30 -25.36% = — × — × -39.52% × 0.47 × 1.33
2021/03/31 -34.53% = — × — × -81.87% × 0.31 × 1.32
2020/12/31 -29.11% = — × — × -95.01% × 0.25 × 1.21
2020/09/30 -27.24% = — × — × -106.74% × 0.21 × 1.18
2020/06/30 -26.32% = — × — × -124.16% × 0.18 × 1.17
2020/03/31 -32.11% = — × — × -110.18% × 0.23 × 1.24
2019/12/31 -26.53% = — × — × -116.72% × 0.19 × 1.20
2019/09/30 — = — × — × — × — × 1.27
2019/06/30 — = — × — × — × — × 1.23
2019/03/31 — = — × — × — × — × 1.22

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期の株主資本利益率(ROE)が低下した主な理由は、財務レバレッジ比率の低下です。

ROAを2つのコンポーネントに分解

Shockwave Medical Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 純利益率 × 資産回転率
2024/03/31 9.95% = 20.75% × 0.48
2023/12/31 9.40% = 20.17% × 0.47
2023/09/30 16.55% = 36.33% × 0.46
2023/06/30 31.01% = 39.56% × 0.78
2023/03/31 30.72% = 43.18% × 0.71
2022/12/31 33.43% = 44.10% × 0.76
2022/09/30 18.50% = 20.48% × 0.90
2022/06/30 13.18% = 15.11% × 0.87
2022/03/31 7.78% = 9.70% × 0.80
2021/12/31 -2.64% = -3.85% × 0.69
2021/09/30 -12.69% = -21.60% × 0.59
2021/06/30 -19.12% = -40.60% × 0.47
2021/03/31 -26.21% = -83.47% × 0.31
2020/12/31 -24.15% = -96.92% × 0.25
2020/09/30 -23.01% = -108.73% × 0.21
2020/06/30 -22.48% = -126.34% × 0.18
2020/03/31 -25.86% = -112.25% × 0.23
2019/12/31 -22.04% = -119.06% × 0.19
2019/09/30 — = — × —
2019/06/30 — = — × —
2019/03/31 — = — × —

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期の総資産利益率(ROA)が上昇した主な理由は、純利益率で測定した収益性の向上です。

ROAを4つの要素に分解

Shockwave Medical Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 税負担 × 利息負担 × EBITマージン × 資産回転率
2024/03/31 9.95% = 0.89 × 0.95 × 24.46% × 0.48
2023/12/31 9.40% = 0.85 × 0.96 × 24.81% × 0.47
2023/09/30 16.55% = 1.49 × 0.97 × 25.09% × 0.46
2023/06/30 31.01% = 1.59 × 0.98 × 25.34% × 0.78
2023/03/31 30.72% = 1.64 × 0.99 × 26.76% × 0.71
2022/12/31 33.43% = 1.79 × 0.98 × 25.06% × 0.76
2022/09/30 18.50% = 0.99 × 0.99 × 21.04% × 0.90
2022/06/30 13.18% = 0.98 × 0.98 × 15.72% × 0.87
2022/03/31 7.78% = 0.98 × 0.96 × 10.21% × 0.80
2021/12/31 -2.64% = — × — × -3.26% × 0.69
2021/09/30 -12.69% = — × — × -20.86% × 0.59
2021/06/30 -19.12% = — × — × -39.52% × 0.47
2021/03/31 -26.21% = — × — × -81.87% × 0.31
2020/12/31 -24.15% = — × — × -95.01% × 0.25
2020/09/30 -23.01% = — × — × -106.74% × 0.21
2020/06/30 -22.48% = — × — × -124.16% × 0.18
2020/03/31 -25.86% = — × — × -110.18% × 0.23
2019/12/31 -22.04% = — × — × -116.72% × 0.19
2019/09/30 — = — × — × — × —
2019/06/30 — = — × — × — × —
2019/03/31 — = — × — × — × —

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期の総資産利益率(ROA)が上昇した主な理由は、税負担率で測定した税の効果の増加です。

当期純利益率の分解

Shockwave Medical Inc.、純利益率の分解(四半期データ)

Microsoft Excel
純利益率 = 税負担 × 利息負担 × EBITマージン
2024/03/31 20.75% = 0.89 × 0.95 × 24.46%
2023/12/31 20.17% = 0.85 × 0.96 × 24.81%
2023/09/30 36.33% = 1.49 × 0.97 × 25.09%
2023/06/30 39.56% = 1.59 × 0.98 × 25.34%
2023/03/31 43.18% = 1.64 × 0.99 × 26.76%
2022/12/31 44.10% = 1.79 × 0.98 × 25.06%
2022/09/30 20.48% = 0.99 × 0.99 × 21.04%
2022/06/30 15.11% = 0.98 × 0.98 × 15.72%
2022/03/31 9.70% = 0.98 × 0.96 × 10.21%
2021/12/31 -3.85% = — × — × -3.26%
2021/09/30 -21.60% = — × — × -20.86%
2021/06/30 -40.60% = — × — × -39.52%
2021/03/31 -83.47% = — × — × -81.87%
2020/12/31 -96.92% = — × — × -95.01%
2020/09/30 -108.73% = — × — × -106.74%
2020/06/30 -126.34% = — × — × -124.16%
2020/03/31 -112.25% = — × — × -110.18%
2019/12/31 -119.06% = — × — × -116.72%
2019/09/30 — = — × — × —
2019/06/30 — = — × — × —
2019/03/31 — = — × — × —

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期の純利益率が上昇した主な理由は、税負担率で測定した税の影響の増加です。